Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
MS Speaks
*****************************************************
(Abst.) Siponimod following alemtuzumab for SPMS...
0 replies
Impact of previous DMT on effectiveness, safety outcomes in Pw...
0 replies
(Abst.) Alemtuzumab and rx medication use in the MS population
0 replies
(Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion...
0 replies
(ACTRIMS) Fatal intercerebral hemorrhage secondary to alemtuzu...
0 replies
(Abst.) ANCA-associated life-threatening systemic vasculitis a...
0 replies
Refractory chronic spontaneous urticaria after Lemtrada in MS
0 replies
(Abst.) Alemtuzumab-induced lung injury in 3 MS patients
0 replies
(MS Journal editorial) Emerging safety issues in alemtuzumab-t...
0 replies
EMA to restrict use of alemtuzumab pending review
0 replies
*****************************************************
Next Page
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.